|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ALLERGY IMMUNO TECHNOLOGIES INC, 10KSB40, 2000-09-13 |
Next: ALLERGY IMMUNO TECHNOLOGIES INC, 10KSB40, EX-99.1, 2000-09-13 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> MAY-31-2000
<PERIOD-END> MAY-31-2000
<CASH> 2,603
<SECURITIES> 0
<RECEIVABLES> 21,341
<ALLOWANCES> 9,337
<INVENTORY> 4,377
<CURRENT-ASSETS> 23,586
<PP&E> 46,582
<DEPRECIATION> 46,276
<TOTAL-ASSETS> 82,096
<CURRENT-LIABILITIES> 291,558
<BONDS> 0
0
0
<COMMON> 17,170
<OTHER-SE> (226,632)
<TOTAL-LIABILITY-AND-EQUITY> 84,175
<SALES> 79,976
<TOTAL-REVENUES> 79,976
<CGS> 94,361
<TOTAL-COSTS> 94,361
<OTHER-EXPENSES> 163,699
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (178,084)
<INCOME-TAX> 800
<INCOME-CONTINUING> (177,786)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (177,786)
<EPS-BASIC> (.01)
<EPS-DILUTED> (.01)
</TABLE>
|
|